← Open Payments lookup

JACOB NGUYEN: Open Payments

NPI 1679249098 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,266 in 69 payments from 7 companies in 2025. Trend: 2023 $784 · 2024 $1,131 · 2025 $1,266

Food & beverage: $1,266
CompanyPaymentsAmount
Madrigal Pharmaceuticals23$570
Gilead Sciences, Inc.15$212
Ipsen Biopharmaceuticals, Inc8$177
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$161
Intercept Pharmaceuticals, Inc.3$70
AstraZeneca Pharmaceuticals LP2$61
ABBVIE INC.1$14

Products named: REZDIFFRA, IQIRVO, XIFAXAN, OCALIVA, MAVYRET.

Industry payments across AZ — which companies pay providers there.